Intellia Therapeutics (NTLA)Director sold ~$2.3K
Muna Bhanji, Director at Intellia Therapeutics, sold ~$2.3K of Intellia Therapeutics shares.
- ~$2.3K
- Approx. value · 265 sh @ $8.50
- 19K
- Holds after · shares reported
- Traded
- Apr 29, 2025
- Filed
- May 1, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 4, 2025Insider · 2 peopleInsiders: 2 sales (~$29K)
- Apr 29, 2025 · this disclosureInsiderDirector sold ~$2.3K of NTLA shares in the open market
What came next
- Jun 30, 2025InsiderDirector sold ~$15K of NTLA shares in the open market
- Jul 1, 2025Insider · 2 peopleInsiders: 2 sales (~$24K)
- Jul 2, 2025InsiderOfficer sold ~$25K of NTLA shares in the open market
- Jul 23, 2025InsiderCFO sold ~$105K of NTLA shares in the open market
- Aug 20, 2025InsiderDirector purchased ~$1M of NTLA shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Intellia Therapeutics
For Intellia Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NTLA page.
Other recent filings by Muna Bhanji, Director
- SEC Form 4 at Veracyte, Inc. (VCYT)Jun 17, 2025
- SEC Form 4 at Cytokinetics (CYTK)May 15, 2025
- SEC Form 4 at Intellia Therapeutics (NTLA)Jan 31, 2025
The full history of Muna Bhanji, Director is on the profile page.
How this filing works
Other disclosures at Intellia Therapeutics
- SEC Form 4Oct 7, 2026
- SEC Form 144Oct 5, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRMay 15, 2026
Everything OQRO holds on this company is on its NTLA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data